Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STAAR SURGICAL COSTAA · Entity 4851 | Director | June 18, 2026 | June 22, 2026 |
| WATERS CORP /DE/WAT · Entity 3080 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STAAR SURGICAL CO
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 77,127 |
Reported balance
After 2026-06-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-18 · Exercise / conversion · Acquired 10,683 · Balance 77,127 F1: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-18 · Exercise / conversion · Disposed 10,683 · Balance 0 F1: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 6,182 |
Reported balance
After 2026-06-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-18 · Grant · Acquired 6,182 · Balance 6,182 F2: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.
F2: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.
WATERS CORP /DE/
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,630.16 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 57.41 · Balance 3,630.16 F1: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur automatically upon the Reporting Person's termination of service as a member of the Issuer's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur automatically upon the Reporting Person's termination of service as a member of the Issuer's Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 01:08 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 57.41 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000136 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,630.16 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur automatically upon the Reporting Person's termination of service as a member of the Issuer's Board of Directors. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:24 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 67.42 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000117 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,572.75 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur automatically upon the Reporting Person's termination of service as a member of the Issuer's Board of Directors. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 6,182 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001867980-26-000006 · ownership.xml · derivative · entry 3 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,182 Underlying: Common Stock · 6,182 shares Expires not disclosed F2 · security: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. F2 · derivative.exercise_date: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. F2 · derivative.expiration_date: Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 10,683 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001867980-26-000006 · ownership.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,683 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. F1 · derivative.exercise_date: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. F1 · derivative.expiration_date: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:05 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 10,683 | $0.00 | $0.00 |
DisclosureSEC source: 0001867980-26-000006 · ownership.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:03 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 64.06 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000109 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,505.33 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2036, pursuant to an election previously made by the Reporting Person. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 20:37 UTC | WATERS CORP /DE/ WAT · Entity 3080 | PurchaseCommon Stock | 500 | $289.46 | $144,730.00 |
DisclosureSEC source: 0001000697-26-000105 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,441.27 Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:21 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 57 | $0.00 Strike: $319.44 | $0.00 |
DisclosureSEC source: 0001000697-26-000081 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57 Underlying: Common Stock · 57 shares Expires 2036-02-25 F2 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027. Read SEC document |
| February 25, 2026 Filed Feb 28, 2026 00:21 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 23 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000081 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,941.27 F1 · shares: Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 22:48 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 20,967 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-013155 · ownership.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F1 · derivative.exercise_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025, 1/3 (20,967 shares) on November 12, 2025, and 1/3 (20,967 shares) on January 12, 2026. F1 · derivative.expiration_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025, 1/3 (20,967 shares) on November 12, 2025, and 1/3 (20,967 shares) on January 12, 2026. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 22:48 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 20,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-013155 · ownership.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025, 1/3 (20,967 shares) on November 12, 2025, and 1/3 (20,967 shares) on January 12, 2026. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:30 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 828 | $0.00 Strike: $381.96 | $0.00 |
DisclosureSEC source: 0001000697-26-000014 · form4.xml · derivative · entry 3 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 828 Underlying: Common Stock · 828 shares Expires 2036-01-02 F3 · shares: All of the shares of common stock underlying this stock option will vest and become exercisable on January 2, 2027. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:30 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 307 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000014 · form4.xml · nonDerivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,918.27 F2 · shares: Represents shares of common stock subject to restrictions that will lapse with respect to 100% of the shares on January 2, 2027. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 22:30 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 59.79 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-26-000014 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,611.27 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2035, pursuant to an election previously made by the Reporting Person. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 23:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 20,967 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-283413 · ownership.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,967 Underlying: Common Stock · 20,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F1 · derivative.exercise_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025 and 1/3 (20,967 shares) on November 12, 2025, and will vest as 1/3 (20,967 shares) on January 12, 2026. F1 · derivative.expiration_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025 and 1/3 (20,967 shares) on November 12, 2025, and will vest as 1/3 (20,967 shares) on January 12, 2026. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 23:00 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 20,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-283413 · ownership.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025 and 1/3 (20,967 shares) on November 12, 2025, and will vest as 1/3 (20,967 shares) on January 12, 2026. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:15 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 72.91 | $0.00 | $0.00 |
DisclosureSEC source: 0001000697-25-000007 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,551.48 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2035, pursuant to an election previously made by the Reporting Person. Read SEC document |
| August 12, 2025 Filed Aug 13, 2025 22:39 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionRestricted Stock Units · Derivative | 20,967 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-108237 · ownership.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,934 Underlying: Common Stock · 20,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F1 · derivative.exercise_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025, and will vest as to 1/3 (20,967 shares) on November 12, 2025, and 1/3 (20,967 shares) on January 12, 2026. F1 · derivative.expiration_date: Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025, and will vest as to 1/3 (20,967 shares) on November 12, 2025, and 1/3 (20,967 shares) on January 12, 2026. Read SEC document |
| August 12, 2025 Filed Aug 13, 2025 22:39 UTC | STAAR SURGICAL CO STAA · Entity 4851 | Exercise / conversionCommon Stock | 20,967 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-108237 · ownership.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025, and will vest as to 1/3 (20,967 shares) on November 12, 2025, and 1/3 (20,967 shares) on January 12, 2026. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 23:18 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 68.35 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-018410 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,478.57 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2035, pursuant to an election previously made by the Reporting Person. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 21:22 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 10,683 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-088594 · ownership.xml · derivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,683 Underlying: Common Stock · 10,683 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: These equity awards vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders. F2 · derivative.expiration_date: These equity awards vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders. Read SEC document |
| May 12, 2025 Filed May 13, 2025 22:02 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 62,901 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-070613 · ownership.xml · derivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,901 Underlying: Common Stock · 62,901 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F2 · derivative.exercise_date: Award of RSUs granted to the Reporting Person on May 12, 2025. RSUs will vest as to 1/3 of the shares subject to the award on August 12, 2025, November 12, 2025, and January 12, 2026. F2 · derivative.expiration_date: Award of RSUs granted to the Reporting Person on May 12, 2025. RSUs will vest as to 1/3 of the shares subject to the award on August 12, 2025, November 12, 2025, and January 12, 2026. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:12 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 52.95 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-011182 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,410.22 F1 · shares: Represents common stock units received in lieu of cash payment of director fees pursuant to the Issuer's 1996 Non-Employee Director Deferred Compensation Plan. Common stock units are convertible into shares of the Issuer's common stock on a one-for-one basis upon distribution, which will occur on January 1, 2035, pursuant to an election previously made by the Reporting Person. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 18:27 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 818 | $0.00 Strike: $368.26 | $0.00 |
DisclosureSEC source: 0001127602-25-000651 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 818 Underlying: Common Stock · 818 shares Expires 2035-01-02 F2 · shares: Options vest in full on January 2, 2026. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 18:27 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 319 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-000651 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,357.27 F1 · shares: Represents shares of restricted stock which will vest in full on January 2, 2026. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 15:12 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 80.65 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-000155 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,038.27 F1 · price: THE REPORTED SECURITIES ARE COMMON STOCK UNITS WHICH ARE CONVERTIBLE INTO SHARES OF COMMON STOCK ON A ONE-TO-ONE RATIO. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 15:44 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 62.97 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-024821 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,957.62 F1 · price: THE REPORTED SECURITIES ARE COMMON STOCK UNITS WHICH ARE CONVERTIBLE INTO SHARES OF COMMON STOCK ON A ONE-TO-ONE RATIO. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 15:26 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 64.24 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-019671 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,894.65 F1 · price: THE REPORTED SECURITIES ARE COMMON STOCK UNITS WHICH ARE CONVERTIBLE INTO SHARES OF COMMON STOCK ON A ONE-TO-ONE RATIO. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:02 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock Options · Derivative | 4,010 | $0.00 Strike: $40.11 | $0.00 |
DisclosureSEC source: 0000950170-24-076857 · ownership.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,010 Underlying: Common Stock · 4,010 shares Expires 2034-06-19 F1 · security: Reflects shares of restricted stock and options to purchase common stock granted on June 20, 2024, pursuant to the Corporation's annual non-employee director equity compensation program for the 2024-2025 term. These equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 21:02 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 2,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076857 · ownership.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,543 F1 · security: Reflects shares of restricted stock and options to purchase common stock granted on June 20, 2024, pursuant to the Corporation's annual non-employee director equity compensation program for the 2024-2025 term. These equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 16:04 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 62.36 | $328.72 Strike: $0.00 | $20,498.98 |
DisclosureSEC source: 0001127602-24-011503 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62.36 Underlying: Common Stock · 62.36 shares Expires not disclosed F1 · security: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO. F2 · shares: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO F3 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:11 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantRestricted Stock Units · Derivative | 1,061 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-031653 · ownership.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,061 Underlying: Common Stock · 1,061 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting. F3 · derivative.exercise_date: RSUs granted as compensation for services as a director to non-employee directors who elected to receive shares in lieu of director cash compensation fees. Mr. Jiang has elected to defer delivery of these shares. F3 · derivative.expiration_date: RSUs granted as compensation for services as a director to non-employee directors who elected to receive shares in lieu of director cash compensation fees. Mr. Jiang has elected to defer delivery of these shares. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:11 UTC | STAAR SURGICAL CO STAA · Entity 4851 | GrantCommon Stock | 1,299 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-031653 · ownership.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,299 F1 · shares: Effective March 12, 2024, the Board of Directors appointed Mr. Jiang to serve as a member of the Board and granted him, as a non-employee director, 1,299 restricted shares, which represents a pro-rated amount of the standard director equity compensation for a director serving during the 2023-2024 term. These restricted shares vest in full on the earlier of June 20, 2024, or the Corporation's 2024 Annual Meeting of Shareholders. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 16:18 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 847 | $0.00 Strike: $328.62 | $0.00 |
DisclosureSEC source: 0001127602-24-000230 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 847 Underlying: Common Stock · 847 shares Expires 2034-01-03 F2 · shares: Options fully vest on January 3, 2025 Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 16:18 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-000230 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,100 F1 · shares: Grants of shares of common stock subject to restrictions that lapse January 3, 2025 Read SEC document |
| December 29, 2023 Filed Jan 3, 2024 15:21 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 90.52 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-000215 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90.52 Underlying: Common Stock · 90.52 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 14:57 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 74.18 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025048 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74.18 Underlying: Common Stock · 74.18 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO. F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 19:10 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 73.66 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019933 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73.66 Underlying: Common Stock · 73.66 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO F2 · derivative.exercise_date: UPON RESIGNATION AS DIRECTOR. F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 16:00 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 68.01 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-012475 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68.01 Underlying: Common Stock · 68.01 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO F2 · derivative.exercise_date: UPON RESIGNATION AS DIRECTOR. F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 14:56 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 827 | $0.00 Strike: $345.59 | $0.00 |
DisclosureSEC source: 0001127602-23-000748 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 827 Underlying: Common Stock · 827 shares Expires 2033-01-03 F2 · shares: Options fully vest on January 3, 2024 Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 14:56 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 318 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-000748 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766 F1 · shares: Grant of shares of common stock subject to restrictions that lapse January 3, 2024 Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 13:51 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 69.54 | $0.00 Strike: $316.35 | $0.00 |
DisclosureSEC source: 0001127602-23-000241 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69.54 Underlying: Common Stock · 69.54 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO. F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 13:23 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 59.52 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023341 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59.52 Underlying: Common Stock · 59.52 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 16:06 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 74.03 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018621 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74.03 Underlying: Common Stock · 74.03 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 16:47 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 67.62 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011013 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67.62 Underlying: Common Stock · 67.62 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:54 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 983 | $0.00 Strike: $364.59 | $0.00 |
DisclosureSEC source: 0001127602-22-000760 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 983 Underlying: Common Stock · 983 shares Expires 2032-01-03 F2 · shares: Options fully vest on January 3, 2023. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:54 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantCommon Stock | 301 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000760 · form4.xml · nonDerivative · entry 1 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448 F1 · shares: Grant of shares of common stock subject to restrictions that lapse January 3, 2023. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 20:59 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 56.46 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000402 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56.46 Underlying: Common Stock · 56.46 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO. F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 14:00 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantPhantom Stock Units · Derivative | 34.51 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026378 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34.51 Underlying: Common Stock · 34.51 shares Expires not disclosed F1 · derivative.exercise_price: COMMON STOCK UNITS ARE CONVERTIBLE INTO COMMON STOCK SHARES ON A ONE TO ONE RATIO F2 · derivative.expiration_date: UPON RESIGNATION AS DIRECTOR. Read SEC document |
| July 14, 2021 Filed Jul 15, 2021 20:40 UTC | WATERS CORP /DE/ WAT · Entity 3080 | GrantStock Option (Right to Buy) · Derivative | 537 | $371.64 Strike: $371.64 | $199,570.68 |
DisclosureSEC source: 0001127602-21-022013 · form4.xml · derivative · entry 2 Jiang Wei · CIK 0001867980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537 Underlying: Common Stock · 537 shares Expires 2031-07-14 F2 · shares: These options vest 20% per annum for a 5 year period starting July 14, 2022 F2 · derivative.exercise_date: These options vest 20% per annum for a 5 year period starting July 14, 2022 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.